The University of Western Australia
Assoc/Prof Naomi Trengove
Associate Professor
Contact details
| Address | Biochemistry and Molecular Biology The University of Western Australia (M310) 35 Stirling Highway CRAWLEY WA 6009 Australia |
|---|---|
| Phone | 6488 4421 |
| Fax | 6488 1148 |
| naomi.trengove@uwa.edu.au |
Location
Room 204, Molecular and Chemical Sciences Building, Crawley campus
Biography
Qualifications
RGN: Royal Adelaide Hospital 1984
BSc. Hons: University of Western Australia, 1990
PhD: The University of Western Australia –1996
Current Appointments
Lecturer in Biochemistry; The University of Western Australia
Unit Co-ordinator; Normal Systems 2nd Yr Medicine and Dentistry
Naomi trained as a Registered Nurse at the Royal Adelaide Hospital, graduating in 1984. She then worked in the UK as an RN for 3 years before returning to Australia where she continued to work as an RN while completing her BSc at the University of Western Australia. After completing Honours in Biochemistry she worked as a Research Assistant in Physiology and then as a Research Nurse with the UWA Department of Surgery, at Fremantle Hospital, running a clinical trial testing the effects of growth factors on the healing of chronic leg ulcers. This then lead to Naomi completing a PhD in the departments of Biochemistry & Surgery in the area of wound healing. She then worked in this area of clinical research for a number of years investigating the biochemical causes of chronic wounds and their inability to heal.
In 2004 Naomi took up her current lecturing position in Biochemistry and her main role is coordinating units and teaching extensively within the Medical, Dental & Podiatry Degrees.
RGN: Royal Adelaide Hospital 1984
BSc. Hons: University of Western Australia, 1990
PhD: The University of Western Australia –1996
Current Appointments
Lecturer in Biochemistry; The University of Western Australia
Unit Co-ordinator; Normal Systems 2nd Yr Medicine and Dentistry
Naomi trained as a Registered Nurse at the Royal Adelaide Hospital, graduating in 1984. She then worked in the UK as an RN for 3 years before returning to Australia where she continued to work as an RN while completing her BSc at the University of Western Australia. After completing Honours in Biochemistry she worked as a Research Assistant in Physiology and then as a Research Nurse with the UWA Department of Surgery, at Fremantle Hospital, running a clinical trial testing the effects of growth factors on the healing of chronic leg ulcers. This then lead to Naomi completing a PhD in the departments of Biochemistry & Surgery in the area of wound healing. She then worked in this area of clinical research for a number of years investigating the biochemical causes of chronic wounds and their inability to heal.
In 2004 Naomi took up her current lecturing position in Biochemistry and her main role is coordinating units and teaching extensively within the Medical, Dental & Podiatry Degrees.
Key research
- Naomi has been working with Professor Peter Hartmann in the area of lactation research. Peter’s research has a strong emphasis on the comparative biochemistry of lactation. Naomi is specifically involved in the area of biochemical analysis of milk with regard to the establishment of a Human Milk Bank at King Edwards Memorial Hospital in Perth.
Major research interests
- Biochemistry of nutrition
- Endocrinology (hormones)
- Lactation
- Tissue engineering
- Wound healing
Qualifications
BSc PhD W.Aust.
Publications
1.Stacey MC, Langton SR, Mata SD, Trengove NJ “Phospholipase A2 in Chronic Leg Ulcer Healing”. Wound Rep Reg 1994;2:225.
2.“Trengove NJ, Beilefeldt-Ohmann H and Stacey MC. Cytokine Profile of Wound Fluid from Chronic Leg Ulcers”. Wound Rep Reg 1994;2:228.
3.Stacey MC, Langton SR, Mata SD, Trengove NJ “Phospholipase A2 in Chronic Leg Ulcer Healing”.. Primary Intention 1994;2;3:33-34.
4.Trengove NJ, Beilefeldt-Ohmann H, Stacey MC “Cytokine Profile in Chronic Wounds”.. Primary Intention 1994; 2/3: 36.
5.Trengove NJ, Stacey MC and Zheng MH. “Detection of uPA, uPA Receptor and PAI-1 in Chronic Leg Ulcer Biopsies Using in Situ Hybridization”. Phlebology ´95 XII World Congress Union Internationale de Phlébologie, Editors D Negus, G Jantet and P D Coleridge Smith, Vol 2, 1995: 849.
6.Stacey MC, Vandongen YK, Trengove NJ, Hoskin S, Thompson P and Pearce C. “The Effectiveness of Compression in Healing Chronic Venous Ulcers”. Phlebology ´95 XII World Congress Union Internationale de Phlébologie, Editors D Negus, G Jantet and P D Coleridge Smith, Vol 2, 1995: 929-931.
7.Busfield SJ, Chappell DS, Jennings G, Trengove NJ, Riches KJ, Callus BA, Tilbrook PA, Klinken SP. “Erythropoietin exerts transcriptional and translational control over globin synthesis in J2E cells.” Cell Growth & Differentiation 1995; 6(4): 429-37.
8.Trengove NJ, Stacey MC, McGechie DF, Stingemore NF and Mata S, “Qualitative bacteriology and leg ulcer healing”. ”. J Wound Care, June 1996; 5: 277-280.
9.Trengove NJ, Stacey MC and Langton SR “Biochemical analysis of wound fluid from non-healing and healing chronic leg ulcers”.. Wound Rep Reg 1996;4:234-9.
10.Tarnuzzer R, Schultz G, Macauley S, Trengove NJ, and Stacey MC. “Protease levels in fluids collected from chronic venous/arterial leg ulcers before and during healing”. Wound Rep Reg 1996;4:A142.
11.“S Hoskin, YK Vandongen, M England, C Pearce, NJ Trengove The evaluation of Bioband in the management of difficult chronic leg ulcers”. . Primary Intention 1997; 5 (3): 10-14.
12.Yeoh S. Wallace HJ. Stacey MC. and Trengove NJ The effect of hypoxia and cytokines on fibroblast proliferation. Australian and New Zealand Journal of Surgery. 1998;68:530-531.
12. N J Trengove, M C Stacey, S M MaCauley, N Bennett, J Gibson, F Burslem, G Murphy, G Schultz. “Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors”. Wound Rep Reg 1999; 7:442-452.
13.N J Trengove, H Bielefeldt-Ohmann, M C Stacey. “Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers”. Wound Rep Reg 2000; 8:13-25.
14.N J Trengove. “Bacteriology of Wounds” Current Therapeutics 2000; 41(5): 33-37
15.M C Stacey, S D Mata, N J Trengove, C A Mather. “Randomised Double-blind Placebo Controlled Trial of Topical Autologous Platelet Lysate in Venous Ulcer Healing”. Eur J Vasc Endovasc Surg 2000; 20: 296-301.
2.“Trengove NJ, Beilefeldt-Ohmann H and Stacey MC. Cytokine Profile of Wound Fluid from Chronic Leg Ulcers”. Wound Rep Reg 1994;2:228.
3.Stacey MC, Langton SR, Mata SD, Trengove NJ “Phospholipase A2 in Chronic Leg Ulcer Healing”.. Primary Intention 1994;2;3:33-34.
4.Trengove NJ, Beilefeldt-Ohmann H, Stacey MC “Cytokine Profile in Chronic Wounds”.. Primary Intention 1994; 2/3: 36.
5.Trengove NJ, Stacey MC and Zheng MH. “Detection of uPA, uPA Receptor and PAI-1 in Chronic Leg Ulcer Biopsies Using in Situ Hybridization”. Phlebology ´95 XII World Congress Union Internationale de Phlébologie, Editors D Negus, G Jantet and P D Coleridge Smith, Vol 2, 1995: 849.
6.Stacey MC, Vandongen YK, Trengove NJ, Hoskin S, Thompson P and Pearce C. “The Effectiveness of Compression in Healing Chronic Venous Ulcers”. Phlebology ´95 XII World Congress Union Internationale de Phlébologie, Editors D Negus, G Jantet and P D Coleridge Smith, Vol 2, 1995: 929-931.
7.Busfield SJ, Chappell DS, Jennings G, Trengove NJ, Riches KJ, Callus BA, Tilbrook PA, Klinken SP. “Erythropoietin exerts transcriptional and translational control over globin synthesis in J2E cells.” Cell Growth & Differentiation 1995; 6(4): 429-37.
8.Trengove NJ, Stacey MC, McGechie DF, Stingemore NF and Mata S, “Qualitative bacteriology and leg ulcer healing”. ”. J Wound Care, June 1996; 5: 277-280.
9.Trengove NJ, Stacey MC and Langton SR “Biochemical analysis of wound fluid from non-healing and healing chronic leg ulcers”.. Wound Rep Reg 1996;4:234-9.
10.Tarnuzzer R, Schultz G, Macauley S, Trengove NJ, and Stacey MC. “Protease levels in fluids collected from chronic venous/arterial leg ulcers before and during healing”. Wound Rep Reg 1996;4:A142.
11.“S Hoskin, YK Vandongen, M England, C Pearce, NJ Trengove The evaluation of Bioband in the management of difficult chronic leg ulcers”. . Primary Intention 1997; 5 (3): 10-14.
12.Yeoh S. Wallace HJ. Stacey MC. and Trengove NJ The effect of hypoxia and cytokines on fibroblast proliferation. Australian and New Zealand Journal of Surgery. 1998;68:530-531.
12. N J Trengove, M C Stacey, S M MaCauley, N Bennett, J Gibson, F Burslem, G Murphy, G Schultz. “Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors”. Wound Rep Reg 1999; 7:442-452.
13.N J Trengove, H Bielefeldt-Ohmann, M C Stacey. “Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers”. Wound Rep Reg 2000; 8:13-25.
14.N J Trengove. “Bacteriology of Wounds” Current Therapeutics 2000; 41(5): 33-37
15.M C Stacey, S D Mata, N J Trengove, C A Mather. “Randomised Double-blind Placebo Controlled Trial of Topical Autologous Platelet Lysate in Venous Ulcer Healing”. Eur J Vasc Endovasc Surg 2000; 20: 296-301.
Roles, responsibilities and expertise
In 2008 Naomi was appointed Associate Dean Teaching and Learning for the Faculty of Medicine, Dentistry and Health Science, and as such is involved in the management and development of the medical curriculum. She sits on several committees, including teaching and learning, evaluation and the medical curriculum committee.
Teaching
Dr Trengove is the unit co-ordinator for IMED2201 Normal Systems, the biochemistry co-orinator for the Graduate Entry Medical Program, and lectures in biochemistry and molular biology for first and second year courses.
Useful links
Human">http://www.biomedchem.uwa.edu.au/research/human-lactation">Human Lactation Research Group
Research profile
